Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: J Nucl Med. 2014 Mar 13;55(5):812–817. doi: 10.2967/jnumed.113.133850

TABLE 1.

Biodistribution Results of 64CuCl2 in B16F10 and A375M Tumor-Bearing Mice (n = 4)

Organ B16F10 A375M
Blood   1.51 ± 0.19   1.94 ± 0.56
Heart   5.16 ± 0.73   8.85 ± 0.65
Lungs   6.64 ± 0.48 10.17 ± 1.58
Liver 14.06 ± 2.33 13.37 ± 1.32
Spleen   3.46 ± 0.42   4.59 ± 0.10
Pancreas   2.74 ± 0.36   3.48 ± 0.61
Stomach   3.92 ± 0.82   6.47 ± 0.86
Brain   0.88 ± 0.09   1.00 ± 0.07
Intestine   4.35 ± 0.99   6.82 ± 0.40
Kidneys 11.86 ± 0.56 10.34 ± 0.53
Skin   1.18 ± 0.51   1.95 ± 0.36
Muscle   1.03 ± 0.18   1.13 ± 0.36
Bone   1.66 ± 0.24   1.82 ± 0.24
Tumor   4.14 ± 0.24   3.59 ± 0.36
Uptake ratio
 Tumor to blood   2.79 ± 0.42   1.94 ± 0.44
 Tumor to lung   0.63 ± 0.07   0.36 ± 0.04
 Tumor to liver   0.30 ± 0.04   0.26 ± 0.04
 Tumor to muscle   4.11 ± 0.07   3.46 ± 1.25

Data are presented as percentage injected dose per gram (%ID/g) ± SD.